Follow
John E. Levine
John E. Levine
Verified email at mssm.edu
Title
Cited by
Cited by
Year
Graft-versus-host disease
JLM Ferrara, JE Levine, P Reddy, E Holler
The Lancet 373 (9674), 1550-1561, 2009
30642009
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium
AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ...
Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016
6722016
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and …
E Holler, P Butzhammer, K Schmid, C Hundsrucker, J Koestler, K Peter, ...
Biology of Blood and Marrow Transplantation 20 (5), 640-645, 2014
5452014
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ...
Nature medicine 24 (10), 1504-1506, 2018
4812018
A biomarker panel for acute graft-versus-host disease
S Paczesny, OI Krijanovski, TM Braun, SW Choi, SG Clouthier, R Kuick, ...
Blood, The Journal of the American Society of Hematology 113 (2), 273-278, 2009
4652009
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
JD Geiger, RJ Hutchinson, LF Hohenkirk, EA McKenna, GA Yanik, ...
Cancer research 61 (23), 8513-8519, 2001
4252001
Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency
DA Williams, W Tao, F Yang, C Kim, Y Gu, P Mansfield, JE Levine, ...
Blood, The Journal of the American Society of Hematology 96 (5), 1646-1654, 2000
4182000
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
MT Vander Lugt, TM Braun, S Hanash, J Ritz, VT Ho, JH Antin, Q Zhang, ...
New England Journal of Medicine 369 (6), 529-539, 2013
4162013
Integrative clinical sequencing in the management of refractory or relapsed cancer in youth
RJ Mody, YM Wu, RJ Lonigro, X Cao, S Roychowdhury, P Vats, KM Frank, ...
Jama 314 (9), 913-925, 2015
3912015
EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ...
Bone marrow transplantation 53 (11), 1401-1415, 2018
3592018
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
JLM Ferrara, AC Harris, JK Greenson, TM Braun, E Holler, T Teshima, ...
Blood, The Journal of the American Society of Hematology 118 (25), 6702-6708, 2011
3572011
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
JE Levine, T Braun, SL Penza, P Beatty, K Cornetta, R Martino, ...
Journal of Clinical Oncology 20 (2), 405-412, 2002
3232002
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
JE Levine, TM Braun, AC Harris, E Holler, A Taylor, H Miller, J Magenau, ...
The Lancet Haematology 2 (1), e21-e29, 2015
2922015
Donor leukocyte infusions in acute lymphocytic leukemia
RH Collins Jr, S Goldstein, S Giralt, J Levine, D Porter, W Drobyski, ...
Bone marrow transplantation 26 (5), 511-516, 2000
2922000
Elafin is a biomarker of graft-versus-host disease of the skin
S Paczesny, TM Braun, JE Levine, J Hogan, J Crawford, B Coffing, ...
Science translational medicine 2 (13), 13ra2-13ra2, 2010
2902010
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
ML MacMillan, M Robin, AC Harris, TE DeFor, PJ Martin, A Alousi, VT Ho, ...
Biology of Blood and Marrow Transplantation 21 (4), 761-767, 2015
2792015
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, ...
JCI insight 2 (3), 2017
2412017
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant …
AM Alousi, DJ Weisdorf, BR Logan, J Bolanos-Meade, S Carter, ...
Blood, The Journal of the American Society of Hematology 114 (3), 511-517, 2009
2362009
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
JE Levine, S Paczesny, S Mineishi, T Braun, SW Choi, RJ Hutchinson, ...
Blood, The Journal of the American Society of Hematology 111 (4), 2470-2475, 2008
2352008
Pathogenesis and management of graft-versus-host disease
SW Choi, JE Levine, JLM Ferrara
Immunology and Allergy Clinics 30 (1), 75-101, 2010
2212010
The system can't perform the operation now. Try again later.
Articles 1–20